Variant report
Variant | esv3455381 |
---|---|
Chromosome Location | chr21:41216942-41217224 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:41217185..41219061-chr21:41222120..41225163,3 | MCF-7 | breast: | |
2 | chr21:41214087..41216615-chr21:41216741..41221047,4 | MCF-7 | breast: | |
3 | chr21:41216229..41218575-chr21:41247366..41250074,2 | K562 | blood: | |
4 | chr21:41208734..41211279-chr21:41216423..41218516,2 | K562 | blood: | |
5 | chr21:41215857..41218519-chr21:41265532..41267969,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537084297 | chr21:41216954-41216955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73221269 | chr21:41216978-41216979 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs570156082 | chr21:41216988-41216989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576573676 | chr21:41216995-41216996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs59997683 | chr21:41217021-41217022 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs111903970 | chr21:41217041-41217042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573007836 | chr21:41217108-41217109 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs367567296 | chr21:41217109-41217110 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541732111 | chr21:41217123-41217124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562046646 | chr21:41217135-41217136 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371672943 | chr21:41217149-41217150 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117874629 | chr21:41217150-41217151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs59022163 | chr21:41217156-41217157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543881667 | chr21:41217160-41217161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9979170 | chr21:41217173-41217174 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs189585685 | chr21:41217186-41217187 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552715330 | chr21:41217188-41217189 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559657919 | chr21:41217202-41217203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376847768 | chr21:41217207-41217208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs151081262 | chr21:41217216-41217217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181430063 | chr21:41217224-41217225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Down syndrome | 20877625 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21147910 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:41199000-41219800 | Weak transcription | Pancreas | Pancrea |
2 | chr21:41213200-41217000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr21:41213400-41222800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr21:41213600-41223600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr21:41216800-41217400 | Enhancers | NH-A | brain |
6 | chr21:41217000-41217400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr21:41217000-41217400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr21:41217000-41218000 | Enhancers | Placenta Amnion | Placenta Amnion |
9 | chr21:41217200-41217800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr21:41217200-41218400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr21:41217200-41218400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |